Quest Diagnostics Inc (NYSE:DGX)
$ 153.02 0 (0%) Market Cap: 17.08 Bil Enterprise Value: 23.40 Bil PE Ratio: 20.57 PB Ratio: 2.52 GF Score: 86/100

Quest Diagnostics Inc at Jefferies Healthcare Conference Transcript

Jun 10, 2022 / 03:00PM GMT
Release Date Price: $131.25 (-2.70%)
Brian Gil Tanquilut;Stock Analyst
Jefferies LLC, Research Division - Senior Equity

/

All right. Good morning, and welcome to the third day of the 2022 Jefferies Global Healthcare Conference. I'm Brian Tanquilut, I'm the health care services analyst here at Jefferies. And our next presenter is Quest Diagnostics, the leading laboratory provider in the U.S. Joining us today are the company's Chairman and CEO, Steve Rusckowski; company's CEO elect, Jim Davis; and the company's Head of IR, Shawn Bevec.

Questions & Answers

Brian Gil Tanquilut;Stock Analyst;Stephen H. Rusckowski
Jefferies LLC, Research Division - Senior Equity;Quest Diagnostics

/

So I'll start, Steve. We were just talking on the sidelines about how 10 years ago, you hosted a sell-side event probably here in the same hotel. So as you look back, so much has changed and you've done so much at Quest. Maybe just a few reflections on your tenure there and where you see Quest today as you transition and pass the baton to Jim.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot